$0.134
+0.001 (+0.91%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
VVOS Prediction & Forecast by Similar Chart Analysis
Alphio's VVOS stock price prediction model matches the current Vivos Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.13 (+0.79%). The 1-week path is $0.14 (+1.49%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Vivos Therapeutics Inc Stock?
Vivos Therapeutics Inc (VVOS) is currently not a strong buy due to its high volatility and substantial losses. The stock is trading at $0.13, down 94.72% year-to-date, and has a low RSI of 39.57, indicating potential weakness. While the company reported a 35% year-over-year revenue increase to $5.2 million in Q2 2026, the net loss widened to $5.5 million, highlighting ongoing financial challenges. The main risk is the company's cash position, with only $1.8 million available, insufficient to fund operations for the next 12 months, which could lead to further dilution or financial distress.
VVOS stock price ended at $0.13 on Friday, after rising +0.91%
Vivos Therapeutics Inc (VVOS) last closed at $0.1337, gaining +0.91%. These facts feed the 1-day and 1-week VVOS price prediction above.
Forecast Drivers
Vivos Therapeutics Inc (VVOS) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches VVOS, ranked by similarity.
Seasonality analysis for VVOS
Historically the probability of a positive October return for VVOS is 0.00%. July offers the highest probability of a positive month at 30.30%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for VVOS
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $2.50 | $2.63 | $2.72 | +1863.52% |
| Nov 2026 | $1.79 | $2.11 | $2.53 | +1477.73% |
| Dec 2026 | $2.03 | $2.50 | $2.98 | +1770.11% |
In 2026, Vivos Therapeutics Inc (VVOS) is projected to range from $1.79 to $2.98.
Vivos Therapeutics Inc 2026 monthly forecast
In Oct 2026, Vivos Therapeutics Inc is projected to average $2.63, with a low of $2.50 and high of $2.72.
In Nov 2026, Vivos Therapeutics Inc is projected to average $2.11, with a low of $1.79 and high of $2.53.
In Dec 2026, Vivos Therapeutics Inc is projected to average $2.50, with a low of $2.03 and high of $2.98.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.